Brain Tumour Surgery in Turkey

Brain tumour surgery in Turkey gives international patients access to JCI-accredited neurosurgical centres, neuro-oncology tumour boards and modern technology such as neuronavigation, intra-operative MRI, awake craniotomy and Gamma Knife radiosurgery, often at a fraction of UK or US prices. It is not an emergency-transfer service: suitability depends entirely on your tumour type, its location, how urgent treatment is and whether you are fit to travel. Unal Cakar is an independent facilitator who arranges a proper imaging and records review with a vetted hospital first, so you only proceed if a qualified neurosurgeon confirms surgery abroad is appropriate and safe for you.

A brain tumour is an abnormal growth of cells inside the skull. Tumours can be benign (slow-growing and non-cancerous, such as many meningiomas, pituitary adenomas or vestibular schwannomas/acoustic neuromas) or malignant (cancerous, such as gliomas including glioblastoma, or secondary metastases that have spread from cancer elsewhere in the body). Surgery has three main aims: to obtain tissue for an exact diagnosis (histology plus molecular markers under the current WHO classification of central nervous system tumours), to remove as much tumour as can be taken out safely, and to relieve pressure and symptoms such as headaches, seizures or weakness.

Surgery is only one part of brain tumour care. Some tumours are best monitored with scans, some are treated mainly with radiotherapy, stereotactic radiosurgery or medication, and many need a combination of surgery followed by radiotherapy and/or chemotherapy. That is why decisions are made by a multidisciplinary neuro-oncology team rather than a single surgeon.

Most operations are performed as a craniotomy: under general anaesthetic, a section of skull is temporarily removed so the surgeon can reach and remove the tumour, then the bone is replaced and secured. Modern centres use image-guided neuronavigation (a GPS-like map built from your MRI), intra-operative neuromonitoring of nerve and brain function, and in some cases intra-operative MRI or fluorescence guidance (5-ALA) to help distinguish tumour from healthy tissue, particularly with high-grade gliomas. For tumours near speech, movement or vision areas, an awake craniotomy with live brain mapping may be used so the team can protect critical functions while you respond to simple tasks.

Not every tumour requires open surgery. Pituitary and some skull-base tumours are often reached through the nose using an endoscopic endonasal (transsphenoidal) approach, with no scalp incision. Where a tumour is deep, multiple or too risky to remove, the surgeon may perform a stereotactic needle biopsy for diagnosis only, or the board may recommend Gamma Knife or CyberKnife radiosurgery, which targets the tumour with focused radiation and no incision. The right technique depends on the tumour and is confirmed after your scans are reviewed.

• JCI-accredited neurosurgical centres with multidisciplinary neuro-oncology tumour boards
• Neuronavigation, intra-operative neuromonitoring, awake craniotomy and Gamma Knife where indicated
• Independent imaging review before travel — you only proceed if surgery abroad is appropriate and safe
• Not an emergency service: urgent or unstable cases must be treated locally without delay
• Full coordination and documented handover to your home oncology team

1. 01

   Records and imaging review

   You share your MRI/CT scans, any previous biopsy or pathology reports and a symptom history. A neurosurgeon at a vetted hospital reviews them and gives an honest opinion on whether surgery abroad is appropriate, or whether you should be treated locally.

2. 02

   Treatment plan and tumour board

   If suitable, your case is discussed by a neuro-oncology multidisciplinary team. You receive a written plan covering the proposed approach (craniotomy, endoscopic, biopsy or radiosurgery), expected hospital stay and any radiotherapy or chemotherapy likely to follow.

3. 03

   Travel, arrival and pre-operative work-up

   Unal coordinates scheduling, airport transfers, accommodation and an interpreter. On arrival you have fresh imaging, blood tests, an anaesthetic assessment and a face-to-face consultation with your neurosurgeon before consent.

4. 04

   Surgery and intensive care

   The operation is performed under the chosen technique. Most patients spend the first one to two days in a neuro-intensive care or high-dependency unit for close monitoring before moving to a ward.

5. 05

   Recovery, pathology and discharge

   You recover on the ward while the removed tissue is analysed. The team confirms the diagnosis, reviews a post-operative scan and advises on next steps before clearing you as fit to travel home.

6. 06

   Aftercare and continuity

   You leave with your operative notes, pathology results, imaging and a follow-up plan to share with your home oncology team. Unal stays reachable to help with reports, queries and any onward radiotherapy or follow-up coordination.

Suitable candidates are patients with a diagnosed or suspected brain tumour that a neurosurgeon, after reviewing current imaging, judges can be operated on safely, and who are medically stable and fit to fly. Planned surgery for benign tumours such as meningiomas, pituitary adenomas and acoustic neuromas, or for accessible gliomas and single metastases, is often well suited to a coordinated trip. This pathway is not appropriate for neurological emergencies, rapidly deteriorating patients, very high intracranial pressure or anyone too unwell to travel safely; these situations must be managed without delay at the nearest capable hospital. Patients on blood thinners, with significant heart or lung disease, or with extensive cancer elsewhere need careful individual assessment, and in some cases the honest advice will be to treat closer to home.

• Access to JCI-accredited neurosurgical centres with high case volumes and subspecialised neuro-oncology teams
• Modern technology including neuronavigation, intra-operative neuromonitoring, awake craniotomy, endoscopic skull-base surgery and Gamma Knife radiosurgery
• Multidisciplinary tumour board review rather than a single-surgeon decision
• Substantially lower cost than equivalent private care in the UK, US or Gulf, with transparent pricing
• An independent, second-opinion-style review before you commit, so you only travel if surgery abroad genuinely makes sense
• Full English-speaking coordination: interpreter, transfers, accommodation and structured documentation for your home team

Most patients spend one to two days in neuro-intensive care and then several days on a ward, with a typical hospital stay of around five to ten days depending on the tumour and how the surgery goes. Headache, tiredness and a tight or numb scalp around the incision are common in the first weeks, and some patients need a short course of steroids and anti-seizure medication. You should not fly home until your surgical team confirms you are fit, which often means staying in Turkey for roughly two to three weeks in total so any post-operative swelling and wound healing can be monitored.

Fuller recovery is gradual and very individual. Fatigue can last weeks to a few months, and some patients need physiotherapy, occupational therapy or speech and language support, especially after surgery near eloquent brain areas. Driving is usually restricted for a period defined by your home country's rules, particularly if you have had seizures. Many patients then go on to radiotherapy and/or chemotherapy at home, so a clear handover to your local oncology team is essential.

What surgery can achieve depends heavily on the tumour type, grade, location and how completely it can be removed. For many benign tumours, complete or near-complete removal can relieve symptoms and offer an excellent long-term outlook, though some require ongoing scan surveillance. For malignant tumours such as gliomas, the goal is maximal safe resection to confirm the precise diagnosis, ease symptoms and improve the effectiveness of follow-on radiotherapy and chemotherapy; it is rarely a one-step cure. A definitive diagnosis from the removed tissue, including molecular markers, is itself a major result because it guides every subsequent treatment decision. No responsible surgeon can guarantee outcomes, and recurrence is possible, which is why long-term follow-up imaging is part of the plan.

Turkey combines internationally accredited hospitals and experienced neurosurgeons with costs that are typically far below private treatment in the UK, US or the Gulf, while offering technology such as intra-operative MRI, neuronavigation and Gamma Knife radiosurgery in the same centres. Unal Cakar works as an independent facilitator and patient advocate, not a clinic: he arranges a genuine imaging and records review, helps you compare options and coordinates the whole journey, but he never performs treatment and never handles your medical fees. You pay the accredited hospital directly, his support is sponsored by vetted partner hospitals, and his job is to make sure you only proceed when qualified neurosurgeons confirm it is appropriate and safe.